S&P ASX All Technology

3,081.10

0.25%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

QGEN

Qiagen NV (QGEN)

Qiagen NV

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:QGEN

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
02/07/2024	23:29	GlobeNewswire Inc.	QIAGEN N.V. to release results for Q2 2024 and hold webcast	NYSE:QGEN	Qiagen NV
28/06/2024	06:05	GlobeNewswire Inc.	QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children	NYSE:QGEN	Qiagen NV
17/06/2024	21:30	GlobeNewswire Inc.	QIAGEN announces 2028 strategy for solid profitable growth	NYSE:QGEN	Qiagen NV
14/06/2024	06:05	GlobeNewswire Inc.	QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs	NYSE:QGEN	Qiagen NV
13/06/2024	06:05	GlobeNewswire Inc.	QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth	NYSE:QGEN	Qiagen NV
12/06/2024	06:05	GlobeNewswire Inc.	QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance	NYSE:QGEN	Qiagen NV
07/06/2024	06:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:QGEN	Qiagen NV
07/06/2024	06:05	GlobeNewswire Inc.	QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period	NYSE:QGEN	Qiagen NV
06/06/2024	06:05	GlobeNewswire Inc.	QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe	NYSE:QGEN	Qiagen NV
03/06/2024	16:00	GlobeNewswire Inc.	QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care	NYSE:QGEN	Qiagen NV
01/06/2024	06:42	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:QGEN	Qiagen NV
31/05/2024	07:55	GlobeNewswire Inc.	QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications	NYSE:QGEN	Qiagen NV
31/05/2024	06:45	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:QGEN	Qiagen NV
31/05/2024	06:05	GlobeNewswire Inc.	QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications	NYSE:QGEN	Qiagen NV
30/05/2024	06:05	GlobeNewswire Inc.	QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine	NYSE:QGEN	Qiagen NV
15/05/2024	06:05	GlobeNewswire Inc.	QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	NYSE:QGEN	Qiagen NV
13/05/2024	16:00	GlobeNewswire Inc.	QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	NYSE:QGEN	Qiagen NV
08/05/2024	06:05	GlobeNewswire Inc.	QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	NYSE:QGEN	Qiagen NV
03/05/2024	06:05	GlobeNewswire Inc.	QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	NYSE:QGEN	Qiagen NV
30/04/2024	06:05	GlobeNewswire Inc.	QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	NYSE:QGEN	Qiagen NV
25/04/2024	06:05	GlobeNewswire Inc.	QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance	NYSE:QGEN	Qiagen NV
09/04/2024	23:48	GlobeNewswire Inc.	QIAGEN N.V. to release results for Q1 2024 and hold webcast	NYSE:QGEN	Qiagen NV
04/04/2024	07:05	GlobeNewswire Inc.	QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024	NYSE:QGEN	Qiagen NV
26/03/2024	07:05	GlobeNewswire Inc.	QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system	NYSE:QGEN	Qiagen NV
19/03/2024	07:05	GlobeNewswire Inc.	QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements	NYSE:QGEN	Qiagen NV
11/03/2024	20:59	GlobeNewswire Inc.	QIAGEN announces Form 20-F annual report filing for 2023 results	NYSE:QGEN	Qiagen NV
28/02/2024	09:44	GlobeNewswire Inc.	QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery	NYSE:QGEN	Qiagen NV
28/02/2024	08:05	GlobeNewswire Inc.	QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification	NYSE:QGEN	Qiagen NV
16/02/2024	08:05	GlobeNewswire Inc.	QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification	NYSE:QGEN	Qiagen NV
09/02/2024	01:47	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:QGEN	Qiagen NV